PORTOLA PHARMACEUTICALS

portola-pharmaceuticals-logo

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include P... RT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.
#People #Financial #Event #Website #More

PORTOLA PHARMACEUTICALS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2003-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.portola.com

Total Employee:
51+

Status:
Closed

Contact:
650.246.7000

Email Addresses:
[email protected]

Total Funding:
1.31 B USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail ReCAPTCHA Cloudflare JS CDN JS Amazon Route 53 Pound Sterling Japanese Yen



Current Advisors List

charles-homcy_image

Charles Homcy Chairman of the Board of Directors @ Portola Pharmaceuticals
Board_member

farah-champsi_image

Farah Champsi Board of Directors @ Portola Pharmaceuticals
Board_member

alan-d-frazier_image

Alan D. Frazier Board Member @ Portola Pharmaceuticals
Board_member

russell-hirsch_image

Russell Hirsch Board Member @ Portola Pharmaceuticals
Board_member

james-topper_image

James Topper Board Member @ Portola Pharmaceuticals
Board_member

jean-george_image

Jean George Member of the Board of Directors @ Portola Pharmaceuticals
Board_member

nicholas-galakatos_image

Nicholas Galakatos Board Member @ Portola Pharmaceuticals
Board_member

Current Employees Featured

mardi-c-dier_image

Mardi C. Dier
Mardi C. Dier CFO @ Portola Pharmaceuticals
CFO
2006-08-01

scott-garland_image

Scott Garland
Scott Garland President & CEO @ Portola Pharmaceuticals
President & CEO
2018-10-01

laura-a-brege_image

Laura A. Brege
Laura A. Brege Member of Board of Directors @ Portola Pharmaceuticals
Member of Board of Directors
2015-01-01

rajiv-patni_image

Rajiv Patni
Rajiv Patni Chief Medical Officer @ Portola Pharmaceuticals
Chief Medical Officer
2020-02-01

sheldon-koenig_image

Sheldon Koenig
Sheldon Koenig Executive Vice President & Chief Commercial Officer @ Portola Pharmaceuticals
Executive Vice President & Chief Commercial Officer
2019-01-01

john-curnutte_image

John Curnutte
John Curnutte Executive Vice President of Research & Development @ Portola Pharmaceuticals
Executive Vice President of Research & Development
2011-02-01

glenn-brame_image

Glenn Brame
Glenn Brame Executive Vice President & Chief Technical Officer @ Portola Pharmaceuticals
Executive Vice President & Chief Technical Officer
2018-07-01

Founder


charles-homcy_image

Charles Homcy

not_available_image

David Phillips

Stock Details


Company's stock symbol is NASDAQ:PTLA

Investors List

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - Portola Pharmaceuticals

healthcare-royalty-partners_image

HealthCare Royalty Partners

HealthCare Royalty Partners investment in Post-IPO Debt - Portola Pharmaceuticals

eastern-capital_image

Eastern Capital

Eastern Capital investment in Series D - Portola Pharmaceuticals

temasek_image

Temasek Holdings

Temasek Holdings investment in Series D - Portola Pharmaceuticals

biogen-idec_image

Biogen Idec

Biogen Idec investment in Corporate Round - Portola Pharmaceuticals

alliancebernstein_image

AllianceBernstein

AllianceBernstein investment in Series C - Portola Pharmaceuticals

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series C - Portola Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series C - Portola Pharmaceuticals

pac-link_image

Pac-Link

Pac-Link investment in Series C - Portola Pharmaceuticals

prospect-venture-partners_image

Prospect Venture Partners

Prospect Venture Partners investment in Series C - Portola Pharmaceuticals

Key Employee Changes

Date New article
2020-02-04 Portola Picks Adamas Pharma’s Patni for Chief Medical Officer Role

Official Site Inspections

http://www.portola.com Semrush global rank: 418.85 K Semrush visits lastest month: 129.78 K

  • Host name: server-3-171-76-121.iad89.r.cloudfront.net
  • IP address: 3.171.76.121
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Portola Pharmaceuticals" on Search Engine

dfkcompany.com © 2022. All rights reserved